Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has informed stock exchanges that its Board of Directors will meet on Friday, October 24, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ending September 30, 2025 (Q2 FY26). In line with SEBI's Insider Trading Regulations, the trading window for dealing in the company's securities will be closed from September 24, 2025 to October 26, 2025, covering both days. During this period, designated insiders and their immediate relatives are prohibited from trading in the company's shares. This is a standard regulatory disclosure made ahead of the quarterly earnings announcement.
This is a routine compliance filing with no direct impact on the stock price. Investors should mark October 24, 2025 as the date for the Q2 FY26 earnings announcement, which could drive short-term price movement based on the results and management commentary.